| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/21/2004 | WO2003000114A9 Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
| 05/21/2004 | WO2002096923B1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 05/21/2004 | WO2002095014A9 Polypeptides having cellobiase activity and polynucleotides encoding same |
| 05/21/2004 | WO2002088337A9 Olfactory ensheathing glia produced by introducing telomerase |
| 05/21/2004 | WO2002067862A3 Regulation of the ctl response by macrophage migration inhibitory factor |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2002014467A8 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 05/21/2004 | WO2001066690A3 Novel compounds |
| 05/21/2004 | WO2000066068A3 Method for inducing growth and enhancing survival of nervous tissue |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | WO2000032745A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/21/2004 | CA2505379A1 A means of producing and utilising a population of disease specific cytotoxic t-lymphocytes |
| 05/21/2004 | CA2504915A1 Allele-specific rna interference |
| 05/21/2004 | CA2504830A1 Organic anion transport polypeptide related protein-4 (oatprp4) gene in tourette syndrome and related disorders |
| 05/21/2004 | CA2486812A1 Substrates, devices, and methods for cellular assays |
| 05/21/2004 | CA2473776A1 Method for the treatment of diseased, degenerated, or damaged tissue using three-dimensional tissue produced in vitro in combination with tissue cells and/or exogenic factors |
| 05/20/2004 | US20040098769 Comprises nucleotide sequences coding single-stranded DNA-binding protein for modulating DNA replication, repair and recombination; tissue engineering |
| 05/20/2004 | US20040098762 Comprises nucleotide sequences coding desaturase for insertion of a double bond into a fatty acyl moiety at the twelfth or fifteenth carbon position in fatty acyl chain; improving vegetable oils |
| 05/20/2004 | US20040098759 Comprises expression vector coding nucleotide sequences for heavy metal transporting P type membrane pump protein for transformation and propagation of crops resistant to heavy metal poisoning and uptake; bioremediation |
| 05/20/2004 | US20040098757 Rodent model homozygous for membrane protein defect associated with angina and arrhythmias for identifying modulators of cardiovascular and cardiac disorders |
| 05/20/2004 | US20040097867 Systems and methods for treating patients with processed lipoaspirate cells |
| 05/20/2004 | US20040097721 Pesticidal toxins and genes from Bacillus laterosporus strains |
| 05/20/2004 | US20040097711 Chimeric monoclonal antibody for diagnosis, prevention and treatment of immunological, nervous system, developmental, muscle and cell proliferative disorders |
| 05/20/2004 | US20040097708 Comprises nucleotide sequences coding membrane protein associated with odor detection for use in biological pest control |
| 05/20/2004 | US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/20/2004 | US20040097703 Cancer antigen peptide for treatment cell proliferative and cancer disorders |
| 05/20/2004 | US20040097458 Providing microprojectiles carrying polynucleic acid sequences; accelerating the microprojectiles at the preselected-cells, with the microprojectiles contacting cells to penetrate vertebrate cells and deposit polynucleic acid |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097451 Modulation of nidogen expression |
| 05/20/2004 | US20040097441 Modulation of NIMA-related kinase 6 expression |
| 05/20/2004 | US20040097439 Useful to study, increase and/or reduce genes expression, and to improve DNA vaccination |
| 05/20/2004 | US20040097414 Genetic engineered Dna; gene therapy |
| 05/20/2004 | US20040096972 Chimeric plasmid comprising a replicative retroviral genome, and uses |
| 05/20/2004 | US20040096971 Using cortical and/or medullary thymic epithelial cells to propagate lymphocytes and generate T cells from hematopoietic stem cells |
| 05/20/2004 | US20040096970 Producing synchronized population of pine somatic embryos for generation and propagation of trees possessing rapid growth rates and improved wood quality; tissue engineering |
| 05/20/2004 | US20040096969 Biocompatibility polymer; insertion into mammals |
| 05/20/2004 | US20040096968 Propagating and differentiating nervous system tissues; tissue engineering and cell replacement therapy |
| 05/20/2004 | US20040096967 Suspension method for producing embryoid bodies, compositions and methods related thereto |
| 05/20/2004 | US20040096966 Replication of biological tissue |
| 05/20/2004 | US20040096965 Activator of fibronectin binding protein and method of its preparation |
| 05/20/2004 | US20040096942 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 05/20/2004 | US20040096940 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096936 Comprises nucleotide sequences coding fibroblast growth factor (FGF) for treating cardiac disorders; tissue engineering; tissue-targeted gene therapy |
| 05/20/2004 | US20040096921 Human plasma hyaluronidase |
| 05/20/2004 | US20040096901 Chineric monocllonal antibody for treatment and prevention transplant rejection, psoriasis, inflammatory bowel, autoimmune and allergic disorders |
| 05/20/2004 | US20040096888 Comprises nucleotide sequences coding cyclin dependent kinase (PELOTA) for diagnosis, treatment, prognosis and prevention of cell proliferative, cardoivascular, inflammatory, arthritic disorders |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096850 For decreasing the phosphorus waste derived from monogastric animal nutrition; feeds |
| 05/20/2004 | US20040096822 HCV antigen/antibody combination assay |
| 05/20/2004 | US20040096817 For drug screening compounds/techniques for prevention/remediation of blood clots; kits |
| 05/20/2004 | US20040096435 Methods for screening compounds that modulate lipid metabolism |
| 05/20/2004 | US20040096432 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells |
| 05/20/2004 | US20040096431 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 05/20/2004 | US20040096430 Method for producing biological tissue in a growth chamber, in particular for transplantation into or onto a human or animal body, comprising applying biological cells to a growth framework, said growth framework defining an initial form of |
| 05/20/2004 | US20040096429 Method for producing cytotoxic T-cells |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/20/2004 | US20040096425 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 05/20/2004 | US20040096424 Modification of gene expression in transgenic plants |
| 05/20/2004 | US20040093795 Floral packaging material having great masters prints thereon |
| 05/19/2004 | EP1420067A1 Chondroitin synthase |
| 05/19/2004 | EP1420031A2 Bone morphogenetic protein (BMP)-18 compositions |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419261A1 Permeabilisation of cells |
| 05/19/2004 | EP1419259A2 Method for repairing a mutant rna from a dna with genetic defects and for the programmed death of tumour cells by rna trans-splicing as well as a method for identifying naturally trans-spliced cellular rna |
| 05/19/2004 | EP1419257A1 Methylation resistant vectors |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419255A2 A novel group of $g(a)-amylases and a method for identification and production of novel $g(a)-amylases |
| 05/19/2004 | EP1419249A2 TIMM8b-RELATED PROTEIN |
| 05/19/2004 | EP1419245A2 Pseudotyped adeno-associated viruses and uses thereof |
| 05/19/2004 | EP1419241A2 Improved nitroreductase enzymes |
| 05/19/2004 | EP1419240A1 Production and use of human cd124 and cd116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents |
| 05/19/2004 | EP1419236A2 Methods for treating or preventing sclerotic disorders using cd2-binding agents |
| 05/19/2004 | EP1419235A2 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 05/19/2004 | EP1418943A1 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| 05/19/2004 | EP1418936A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 05/19/2004 | EP1418927A1 Cell compositions for use in the treatment of osteo-arthrosis, and method for producing the same |
| 05/19/2004 | EP1418926A2 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 05/19/2004 | EP1418866A2 Xenograft bone matrix for orthopedic applications |
| 05/19/2004 | EP1418814A2 Production of transduced hematopoietic progenitor cells |
| 05/19/2004 | EP1418805A2 Animal model with disrupted $i(fgf14) gene |
| 05/19/2004 | EP1418803A1 Alteration of embryo/endosperm size during seed development |
| 05/19/2004 | EP1261357A4 Isolation and transplantation of retinal stem cells |
| 05/19/2004 | EP1246653B1 Artificial fascial sling or patch |
| 05/19/2004 | EP1229936B1 Use of anti-idiotypical antibodies as vaccines against cancer |
| 05/19/2004 | EP1200478A4 Method for assaying compounds affecting smooth muscle contractile state |
| 05/19/2004 | EP1017810B1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 05/19/2004 | EP1009842B1 Plasmids for plant transformation and method for using the same |
| 05/19/2004 | EP1007551B1 Vaccine against hpv |
| 05/19/2004 | EP0960123A4 Sprouty protein and coding sequence |
| 05/19/2004 | EP0870026B1 Ob protein derivatives having prolonged half-life |
| 05/19/2004 | EP0711173B1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 05/19/2004 | EP0682703B1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
| 05/19/2004 | DE10251918A1 Inheritable integration of DNA into germ-line invertebrate cells, useful for large-scale production of transgenic insects, includes post-transformational removal of mobilizable elements to increase stability |
| 05/19/2004 | DE10251879A1 Medium for measuring effect of tumor therapy on individual cells, useful for selecting treatments, has low buffering capacity in which acidification caused by metabolism of carbon sources is monitored |
| 05/19/2004 | DE10243082A1 Transformed gymnosperm embryo cultures, useful for production of e.g. therapeutic antibodies, immunotoxins or allergens, have high genetic stability and can grow on simple media |
| 05/19/2004 | CN1498272A Modulating developmental transitions in plants |
| 05/19/2004 | CN1498271A Potassium channel interactors protein and uses therefor |
| 05/19/2004 | CN1498267A Cost effective media for large scale insect cell culture |
| 05/19/2004 | CN1497046A Alpha ketonic acid reductase and its preparation method, and method of preparing optical active alpha hydroxy acid using said reductase |